Lv31
210 积分 2025-12-29 加入
Machine learning-based decision support model for selecting intra-arterial therapies for unresectable hepatocellular carcinoma: A national real-world evidence-based study
1个月前
已完结
Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial
2个月前
已完结
Advances in Locoregional and Systemic Treatments for Hepatocellular Carcinoma
2个月前
已完结
Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19–14)
2个月前
已完结
HER2-targeted therapies — a role beyond breast cancer
2个月前
已完结
ERBB receptors and cancer: the complexity of targeted inhibitors
2个月前
已完结
Burden of biliary tract carcinoma in China (1990–2021): Findings from the 2021 Global Burden of Disease Study
2个月前
已完结
Raman Spectroscopy and Exosome-Based Machine Learning Predicts the Efficacy of Neoadjuvant Therapy for HER2-Positive Breast Cancer
2个月前
已完结
Integrating machine learning-predicted circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in metastatic breast cancer: A proof of principle study on endocrine resistance profiling
2个月前
已完结
Automated Quantification of HER2 Amplification Levels Using Deep Learning
2个月前
已完结
皖公网安备34019202002308
